| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Review article |
Department of Medical Microbiology and Infectious Diseases, University of Manitoba, 539-730 William Avenue, Winnipeg, MB, Canada R3E 0W3
Correspondence
Judie Alimonti
judieali{at}yahoo.com
AIDS, caused by the retroviruses human immunodeficiency virus type 1 and type 2 (HIV-1 and HIV-2), has reached pandemic proportions. Therefore, it is critical to understand how HIV causes AIDS so that appropriate therapies can be formulated. Primarily, HIV infects and kills CD4+ T lymphocytes, which function as regulators and amplifiers of the immune response. In the absence of effective anti-retroviral therapy, the hallmark decrease in CD4+ T lymphocytes during AIDS results in a weakened immune system, impairing the body's ability to fight infections or certain cancers such that death eventually ensues. The major mechanism for CD4+ T cell depletion is programmed cell death (apoptosis), which can be induced by HIV through multiple pathways. Death of HIV-infected cells can result from the propensity of infected lymphocytes to form short-lived syncytia or from an increased susceptibility of the cells to death. However, the apoptotic cells appear to be primarily uninfected bystander cells and are eradicated by two different mechanisms: either a Fas-mediated mechanism during activation-induced cell death (AICD), or as a result of HIV proteins (Tat, gp120, Nef, Vpu) released from infected cells stimulating apoptosis in uninfected bystander cells. There is also evidence that as AIDS progresses cytokine dysregulation occurs, and the overproduction of type-2 cytokines (IL-4, IL-10) increases susceptibility to AICD whereas type-1 cytokines (IL-12, IFN-
) may be protective. Clearly there are multiple causes of CD4+ T lymphocyte apoptosis in AIDS and therapies that block or decrease that death could have significant clinical benefit.
Published ahead of print on 22 April 2003 as DOI 10.1099/vir.0.19110-0
This article has been cited by other articles:
|
|
 |
|
  K. L. W. Schultz, J. A. Wetter, D. C. Fiore, and P. D. Friesen Transactivator IE1 Is Required for Baculovirus Early Replication Events That Trigger Apoptosis in Permissive and Nonpermissive Cells J. Virol., January 1, 2009; 83(1): 262 - 272. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Vieillard, R. Le Grand, J. Dausset, and P. Debre A vaccine strategy against AIDS: An HIV gp41 peptide immunization prevents NKp44L expression and CD4+ T cell depletion in SHIV-infected macaques PNAS, February 12, 2008; 105(6): 2100 - 2104. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. S. Myung, M. Kundu, and S. K. Abboud Eosinophilic Granuloma Manifesting as Painless Cervical Lymphadenopathy in a Patient Positive for Human Immunodeficiency Virus 1 Arch Otolaryngol Head Neck Surg, February 1, 2008; 134(2): 203 - 205. [Full Text] [PDF]
|
|
|
|
|
|
S. L. Murphy and G. N. Gaulton TR1.3 Viral Pathogenesis and Syncytium Formation Are Linked to Env-Gag Cooperation J. Virol., October 1, 2007; 81(19): 10777 - 10785. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Melar, D. E. Ott, and T. J. Hope Physiological Levels of Virion-Associated Human Immunodeficiency Virus Type 1 Envelope Induce Coreceptor-Dependent Calcium Flux J. Virol., February 15, 2007; 81(4): 1773 - 1785. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Ji, J. J-Y. Chen, V. L. Braciale, and M. W. Cloyd Apoptosis induced in HIV-1-exposed, resting CD4+ T cells subsequent to signaling through homing receptors is Fas/Fas ligand-mediated J. Leukoc. Biol., January 1, 2007; 81(1): 297 - 305. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. G. Meissner, L. Zhang, S. Jiang, and L. Su Fusion-Induced Apoptosis Contributes to Thymocyte Depletion by a Pathogenic Human Immunodeficiency Virus Type 1 Envelope in the Human Thymus J. Virol., November 15, 2006; 80(22): 11019 - 11030. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Giri, M. Nebozhyn, L. Showe, and L. J. Montaner Microarray data on gene modulation by HIV-1 in immune cells: 2000-2006 J. Leukoc. Biol., November 1, 2006; 80(5): 1031 - 1043. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Gordon-Alonso, M. Yanez-Mo, O. Barreiro, S. Alvarez, M. A. Munoz-Fernandez, A. Valenzuela-Fernandez, and F. Sanchez-Madrid Tetraspanins CD9 and CD81 Modulate HIV-1-Induced Membrane Fusion J. Immunol., October 15, 2006; 177(8): 5129 - 5137. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Shojania and J. D. O'Neil HIV-1 Tat Is a Natively Unfolded Protein: THE SOLUTION CONFORMATION AND DYNAMICS OF REDUCED HIV-1 Tat-(1-72) BY NMR SPECTROSCOPY J. Biol. Chem., March 31, 2006; 281(13): 8347 - 8356. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Cicala, J. Arthos, E. Martinelli, N. Censoplano, C. C. Cruz, E. Chung, S. M. Selig, D. Van Ryk, J. Yang, S. Jagannatha, et al. R5 and X4 HIV envelopes induce distinct gene expression profiles in primary peripheral blood mononuclear cells PNAS, March 7, 2006; 103(10): 3746 - 3751. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Marchant, S. J. D. Neil, and A. McKnight Human immunodeficiency virus types 1 and 2 have different replication kinetics in human primary macrophage culture J. Gen. Virol., February 1, 2006; 87(2): 411 - 418. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Huang, K. Narayanan, N. Ito, C. J. Peters, and S. Makino Severe Acute Respiratory Syndrome Coronavirus 3a Protein Is Released in Membranous Structures from 3a Protein-Expressing Cells and Infected Cells J. Virol., January 1, 2006; 80(1): 210 - 217. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. R. Campbell, J. D. Watkins, D. Esquieu, E. Pasquier, E. P. Loret, and S. A. Spector The C Terminus of HIV-1 Tat Modulates the Extent of CD178-mediated Apoptosis of T Cells J. Biol. Chem., November 18, 2005; 280(46): 38376 - 38382. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. C. Clay, D. S. Rodrigues, D. J. Harvey, C. M. Leutenegger, and U. Esser Distinct Chemokine Triggers and In Vivo Migratory Paths of Fluorescein Dye-Labeled T Lymphocytes in Acutely Simian Immunodeficiency Virus SIVmac251-Infected and Uninfected Macaques J. Virol., November 1, 2005; 79(21): 13759 - 13768. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. P Galvani The role of mutation accumulation in HIV progression Proc R Soc B, September 7, 2005; 272(1574): 1851 - 1858. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Acheampong, Z. Parveen, L. W. Muthoga, V. Wasmuth-Peroud, M. Kalayeh, A. Bashir, R. Diecidue, M. Mukhtar, and R. J. Pomerantz Molecular Interactions of Human Immunodeficiency Virus Type 1 with Primary Human Oral Keratinocytes J. Virol., July 1, 2005; 79(13): 8440 - 8453. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Schindler, J. Munch, and F. Kirchhoff Human Immunodeficiency Virus Type 1 Inhibits DNA Damage-Triggered Apoptosis by a Nef-Independent Mechanism J. Virol., May 1, 2005; 79(9): 5489 - 5498. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Acheampong, Z. Parveen, L. W. Muthoga, M. Kalayeh, M. Mukhtar, and R. J. Pomerantz Human Immunodeficiency Virus Type 1 Nef Potently Induces Apoptosis in Primary Human Brain Microvascular Endothelial Cells via the Activation of Caspases J. Virol., April 1, 2005; 79(7): 4257 - 4269. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Grelli, G. d'Ettorre, F. Lauria, F. Montella, L. Di Traglia, M. Lichtner, V. Vullo, C. Favalli, S. Vella, B. Macchi, et al. Inverse correlation between CD8+ lymphocyte apoptosis and CD4+ cell counts during potent antiretroviral therapy in HIV patients J. Antimicrob. Chemother., March 1, 2004; 53(3): 494 - 500. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-L. Perfettini, T. Roumier, M. Castedo, N. Larochette, P. Boya, B. Raynal, V. Lazar, F. Ciccosanti, R. Nardacci, J. Penninger, et al. NF-{kappa}B and p53 Are the Dominant Apoptosis-inducing Transcription Factors Elicited by the HIV-1 Envelope J. Exp. Med., March 1, 2004; 199(5): 629 - 640. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
